Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort
Journal of Magnetic Resonance Imaging · 2025
DOI: 10.1002/jmri.29599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Stephane Loubrie und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Diffusion Magnetic Resonance Imaging, Early Detection of Cancer, Magnetic Resonance Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI/NIH, Krueger v. Wyeth Research Award, RSNA Research and Education Foundation.
Abstract (Originalsprache)
Background
Breast cancer screening with dynamic contrast‐enhanced MRI (DCE‐MRI) is recommended for high‐risk women but has limitations, including variable specificity and difficulty in distinguishing cancerous (CL) and high‐risk benign lesions (HRBL) from average‐risk benign lesions (ARBL). Complementary non‐invasive imaging techniques would be useful to improve specificity.
Purpose
To evaluate the performance of a previously‐developed breast‐specific diffusion‐weighted MRI (DW‐MRI) model (BS‐RSI3C) to improve discrimination between CL, HRBL, and ARBL in an enriched screening population. Study Type Prospective. Subjects Exactly 187 women, either with mammography screening recommending additional imaging (N = 49) or high‐risk individuals undergoing routine breast MRI (N = 138), before the biopsy. Field Strength/Sequence Multishell DW‐MRI echo planar imaging sequence with a reduced field of view at 3.0 T. Assessment A total of 72 women had at least one biopsied lesion, with 89 lesions categorized into ARBL, HRBL, CL, and combined CLs and HRBLs (CHRLs). DW‐MRI data were processed to produce apparent diffusion coefficient (ADC) maps, and estimate signal contributions (C 1 , C 2 , and C 3 —restricted, hindered, and free diffusion, respectively) from the BS‐RSI3C model. Lesion regions of interest (ROIs) were delineated on DW images based on suspicious DCE‐MRI findings by two radiologists; control ROIs were drawn in the contralateral breast. Statistical Tests One‐way ANOVA and two‐sided t ‐tests were used to assess differences in signal contributions and ADC values among groups. P ‐values were adjusted using the Bonferroni method for multiple testing, P = 0.05 was used for the significance level. Receiver operating characteristics (ROC) curves and intra‐class correlations (ICC) were also evaluated.
Results
C 1 , √C 1 C 2 , and were significantly different in HRBLs compared with ARBLs ( P ‐values < 0.05). The had the highest AUC (0.821) in differentiating CHRLs from ARBLs, performing better than ADC (0.696), especially in non‐mass enhancement (0.776 vs. 0.517). Data Conclusion This study demonstrated the BS‐RSI3C could differentiate HRBLs from ARBLs in a screening population, and separate CHRLs from ARBLs better than ADC. Level of Evidence 1. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of California San Diego, La Jolla, California, USA.
- Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
- Department of Radiology, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, Republic of Korea.
- Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.
- Department of Research and Innovation, Vestre Viken, Drammen, Norway.
- Department of Radiation Medicine, University of California San Diego, La Jolla, California, USA.
ORCID-Profile: Stephane Loubrie, Ana E Rodriguez-Soto, Christopher C Conlin, Tyler M Seibert, Rebecca Rakow-Penner
Förderung
- NCI/NIH
- Krueger v. Wyeth Research Award
- RSNA Research and Education Foundation
- NCI NIH HHS
- GE Healthcare Research Grant
Zitieren
APA
Loubrie, S., Zou, J., Rodriguez-Soto, A. E., Lim, J., Andreassen, M. M. S., Cheng, Y., Batasin, S. J., Ebrahimi, S., Fang, L. K., Conlin, C. C., Seibert, T. M., Hahn, M. E., Dialani, V., Wei, C. J., Karimi, Z., Kuperman, J., Dale, A. M., Ojeda-Fournier, H., Pisano, E., & Rakow-Penner, R. (2025). Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29599
Vancouver
Loubrie S, Zou J, Rodriguez-Soto AE, Lim J, Andreassen MMS, Cheng Y, et al. Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29599
BibTeX
@article{Loubrie2025,
author = {Loubrie, Stephane and Zou, Jingjing and Rodriguez-Soto, Ana E and Lim, Jihe and Andreassen, Maren M S and Cheng, Yuwei and Batasin, Summer J and Ebrahimi, Sheida and Fang, Lauren K and Conlin, Christopher C and Seibert, Tyler M and Hahn, Michael E and Dialani, Vandana and Wei, Catherine J and Karimi, Zahra and Kuperman, Joshua and Dale, Anders M and Ojeda-Fournier, Haydee and Pisano, Etta and Rakow-Penner, Rebecca},
title = {Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
doi = {10.1002/jmri.29599}
}
EUVIMED